Ashish Chintakuntlawar, MBBS, PhD

  • 393 Citations
  • 10 Scopus h-Index
20072019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ashish Chintakuntlawar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Adenoviridae Medicine & Life Sciences
Keratitis Medicine & Life Sciences
Keratoconjunctivitis Medicine & Life Sciences
Survival Medicine & Life Sciences
Olfactory Esthesioneuroblastoma Medicine & Life Sciences
Human Adenoviruses Medicine & Life Sciences
Oropharynx Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

3 Citations (Scopus)

Diagnosis and Management of Anaplastic Thyroid Cancer

Chintakuntlawar, A., Foote, R. L., Kasperbauer, J. & Bible, K. C., Mar 1 2019, In : Endocrinology and Metabolism Clinics of North America. 48, 1, p. 269-284 16 p.

Research output: Contribution to journalReview article

Mitogen-Activated Protein Kinase Kinases
Chemoradiotherapy
Therapeutics
Mutation
Survival
2 Citations (Scopus)

Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma

Ma, D. J., Price, K. A., Moore, E. J., Patel, S. H., Hinni, M. L., Garcia, J. J., Graner, D. E., Foster, N. R., Ginos, B., Neben-Wittich, M., Garces, Y. I., Chintakuntlawar, A., Price, D. L., Olsen, K. D., Van Abel, K. M., Kasperbauer, J., Janus, J. R., Waddle, M., Miller, R., Shiraishi, S. & 1 others, Foote, R. L., Aug 1 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 22, p. 1909-1918 10 p.

Research output: Contribution to journalArticle

Adjuvant Chemoradiotherapy
Oropharynx
Squamous Cell Carcinoma
Radiotherapy
Deglutition
16 Citations (Scopus)

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L. C., Halfdanarson, T. R., Grothey, A. F., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

CD274 Antigen
Meta-Analysis
Clinical Trials
Incidence
Odds Ratio
2 Citations (Scopus)

Esthesioneuroblastoma with distant metastases: Systematic review & meta-analysis

Marinelli, J. P., Janus, J. R., Van Gompel, J., Link, M. J., Foote, R. L., Lohse, C. M., Price, K. A. & Chintakuntlawar, A., Oct 1 2018, In : Head and Neck. 40, 10, p. 2295-2303 9 p.

Research output: Contribution to journalReview article

Olfactory Esthesioneuroblastoma
Meta-Analysis
Neoplasm Metastasis
Survival
Combination Drug Therapy

Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma

Miller, K. C., Marinelli, J. P., Van Gompel, J., Link, M. J., Janus, J. R., Foote, R. L., Price, K. A., Garcia, J., Rivera, M. & Chintakuntlawar, A., Jan 1 2018, (Accepted/In press) In : Head and Neck.

Research output: Contribution to journalArticle

Olfactory Esthesioneuroblastoma
Adjuvant Radiotherapy
Adjuvant Chemotherapy
Survival
Therapeutics